Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiency Disorders (PIDD)”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Large-scale testing (Phase 3)Active Not RecruitingNCT06076642
What this trial is testing

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 53
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Not applicableStudy completedNCT02176239
What this trial is testing

Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting

Who this might be right for
Primary Immunodeficiency Disease (PIDD)
BriovaRx Infusion Services 20
Large-scale testing (Phase 3)Study completedNCT01218438
What this trial is testing

Phase 2/3 Study of IGSC, 20% in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 86
Not applicableEnded earlyNCT01883921
What this trial is testing

Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

Who this might be right for
Primary Immune Deficiency Disorder
BriovaRx Infusion Services 1,500
Post-approval studies (Phase 4)UnknownNCT05070455
What this trial is testing

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency
ADMA Biologics, Inc. 12
Large-scale testing (Phase 3)Study completedNCT01814800
What this trial is testing

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 59
Large-scale testing (Phase 3)UnknownNCT03238079
What this trial is testing

Study of PlasmaCap IG in Adults and Children With PIDD

Who this might be right for
Primary Immune Deficiency Diseases (PIDD)
Evolve Biologics 74
Post-approval studies (Phase 4)Study completedNCT03116347
What this trial is testing

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 42
Large-scale testing (Phase 3)Study completedNCT03277313
What this trial is testing

Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 44
Large-scale testing (Phase 3)Study completedNCT01485796
What this trial is testing

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 54
Large-scale testing (Phase 3)Study completedNCT05755035
What this trial is testing

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 65
Not applicableUnknownNCT01617122
What this trial is testing

Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Diseases
University of South Florida 200
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableAvailableNCT06955793
What this trial is testing

Expanded Access to TAK-881 for Children and Teenagers With Primary Immunodeficiency Diseases in the USA

Who this might be right for
Primary Immunodeficiency Diseases (PIDD)
Takeda